Completed OBSERVATIONAL NCT03859310

Precision of OCT and OCTA-based Ocular Measurements

Sponsor: Optovue

Conditions Normal Eyes and Ocular Pathology

Interventions SD-OCT

Updated 6 times since 2019 Last updated: Aug 30, 2019 Started: Jan 29, 2019 Primary completion: Jul 10, 2019 Completion: Aug 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03859310, this observational or N/A phase trial focuses on Normal Eyes and Ocular Pathology and remains completed. Sponsored by Optovue, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Feb 2020 — Jan 2021 [monthly]

Completed
Oct 2019 — Feb 2020 [monthly]

Completed

Status: Enrolling By Invitation → Completed

▶ Show 1 earlier version

Apr 2019 — Oct 2019 [monthly]

Enrolling By Invitation

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Optovue

Data source: Optovue

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marysville, United States